X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47508) 47508
Book Review (10973) 10973
Publication (4217) 4217
Newsletter (264) 264
Newspaper Article (207) 207
Book Chapter (206) 206
Conference Proceeding (109) 109
Book / eBook (81) 81
Magazine Article (49) 49
Dissertation (47) 47
Web Resource (21) 21
Data Set (4) 4
Presentation (4) 4
Trade Publication Article (3) 3
Streaming Video (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (43687) 43687
humans (43114) 43114
oncology (23805) 23805
female (20986) 20986
male (19526) 19526
colorectal cancer (19151) 19151
cancer (16194) 16194
middle aged (16178) 16178
aged (15076) 15076
colorectal neoplasms - drug therapy (13426) 13426
colorectal-cancer (12370) 12370
colorectal neoplasms - pathology (11251) 11251
adult (11186) 11186
chemotherapy (10883) 10883
animals (9830) 9830
antineoplastic combined chemotherapy protocols - therapeutic use (7256) 7256
metastasis (7099) 7099
treatment outcome (6977) 6977
care and treatment (6612) 6612
prognosis (6606) 6606
cell line, tumor (6476) 6476
tumors (6440) 6440
research (6426) 6426
aged, 80 and over (5965) 5965
surgery (5787) 5787
mice (5612) 5612
antineoplastic agents - therapeutic use (5476) 5476
apoptosis (5258) 5258
colorectal neoplasms - genetics (5209) 5209
analysis (4991) 4991
health aspects (4845) 4845
fluorouracil - administration & dosage (4798) 4798
medicine & public health (4628) 4628
expression (4590) 4590
fluorouracil (4541) 4541
breast-cancer (4258) 4258
survival (4241) 4241
carcinoma (4058) 4058
neoplasm staging (3994) 3994
liver neoplasms - secondary (3925) 3925
pharmacology & pharmacy (3885) 3885
colon cancer (3853) 3853
colon-cancer (3773) 3773
colorectal neoplasms - metabolism (3773) 3773
gastroenterology & hepatology (3715) 3715
therapy (3680) 3680
risk factors (3647) 3647
genetic aspects (3594) 3594
cancer therapies (3563) 3563
mutation (3385) 3385
oxaliplatin (3367) 3367
gene expression (3342) 3342
retrospective studies (3305) 3305
metastatic colorectal-cancer (3285) 3285
antineoplastic agents - pharmacology (3268) 3268
neoplasm metastasis (3226) 3226
neoplasms - drug therapy (3193) 3193
5-fluorouracil (3157) 3157
proteins (3152) 3152
disease-free survival (3101) 3101
camptothecin - analogs & derivatives (3066) 3066
development and progression (3050) 3050
survival rate (3014) 3014
colorectal neoplasms - mortality (2973) 2973
liver neoplasms - drug therapy (2928) 2928
cell biology (2926) 2926
leucovorin (2923) 2923
drug therapy (2911) 2911
bevacizumab (2843) 2843
apoptosis - drug effects (2838) 2838
medicine (2792) 2792
survival analysis (2790) 2790
research article (2734) 2734
abridged index medicus (2732) 2732
colonic neoplasms - drug therapy (2719) 2719
antineoplastic combined chemotherapy protocols - adverse effects (2689) 2689
leucovorin - administration & dosage (2664) 2664
colonic neoplasms - pathology (2651) 2651
cetuximab (2616) 2616
colorectal carcinoma (2608) 2608
fluorouracil - therapeutic use (2586) 2586
article (2550) 2550
gene expression regulation, neoplastic (2550) 2550
biochemistry & molecular biology (2527) 2527
chemotherapy, adjuvant (2495) 2495
cell proliferation - drug effects (2485) 2485
studies (2448) 2448
irinotecan (2402) 2402
combined modality therapy (2401) 2401
hematology, oncology and palliative medicine (2371) 2371
adenocarcinoma - drug therapy (2355) 2355
immunohistochemistry (2347) 2347
cancer research (2345) 2345
patients (2340) 2340
breast cancer (2337) 2337
cells (2332) 2332
colon (2330) 2330
organoplatinum compounds - administration & dosage (2329) 2329
signal transduction (2248) 2248
oncology, experimental (2238) 2238
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Online Resources - Online (19) 19
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46317) 46317
Japanese (675) 675
German (346) 346
French (309) 309
Chinese (165) 165
Italian (118) 118
Spanish (81) 81
Russian (58) 58
Hungarian (44) 44
Korean (25) 25
Polish (24) 24
Czech (22) 22
Danish (18) 18
Dutch (15) 15
Swedish (13) 13
Portuguese (11) 11
Ukrainian (8) 8
Finnish (6) 6
Norwegian (6) 6
Bulgarian (5) 5
Romanian (5) 5
Serbian (3) 3
Croatian (2) 2
Hebrew (2) 2
Arabic (1) 1
Lithuanian (1) 1
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical colorectal cancer, ISSN 1533-0028, 2001
Journal
Nature Medicine, ISSN 1078-8956, 11/2015, Volume 21, Issue 11, pp. 1318 - 1325
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 10/2014, Volume 6, Issue 10, pp. 1279 - 1293
Epithelial‐mesenchymal transition ( EMT ) is a reversible and dynamic process hypothesized to be co‐opted by carcinoma during invasion and metastasis. Yet,... 
drug response | microarray | gene expression signature | epithelial‐mesenchymal transition | prognosis | Drug response | Epithelial-mesenchymal transition | Prognosis | Microarray | Gene expression signature | MOLECULAR SUBTYPES | MEDICINE, RESEARCH & EXPERIMENTAL | GENE-EXPRESSION SIGNATURE | STEM-CELLS | GENOMIC ANALYSES | OVARIAN-CANCER | NEGATIVE BREAST-CANCER | CLINICAL-RELEVANCE | MICRORNA CONTROL | CLAUDIN-LOW | epithelial-mesenchymal transition | SIGNATURE PREDICTS RESISTANCE | Lung Neoplasms - drug therapy | Oligonucleotide Array Sequence Analysis | Colorectal Neoplasms - genetics | Humans | Epithelial-Mesenchymal Transition - drug effects | Antineoplastic Agents - therapeutic use | Epithelial-Mesenchymal Transition - genetics | Ovarian Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Neoplasms - genetics | Colorectal Neoplasms - drug therapy | Female | Gene Expression Regulation, Neoplastic - drug effects | Ovarian Neoplasms - drug therapy | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Treatment Outcome | Transcriptome - drug effects | Transcriptome - genetics | Stomach Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - genetics | Cell Line, Tumor | Cancer patients | Chemotherapy | Patient outcomes | Stem cells | Development and progression | Drug therapy | Gene expression | Ovarian cancer | Cancer | Medical research | Breast cancer | Tumors | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3167 - 3175
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 26, pp. 2455 - 2465
Antibodies to PD-1 protein and to one of its ligands, PD-L1, have shown antitumor activity. Unleashing T cells from inhibitory signals may be a strategy to... 
MEDICINE, GENERAL & INTERNAL | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | SOLID TUMORS | RESPONSE CRITERIA | CELL ACTIVATION | IMMUNOTHERAPY | B7 FAMILY | ANTITUMOR IMMUNITY | CLINICAL ACTIVITY | PHASE-I | T-CELLS | Neoplasms - metabolism | Humans | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Stomach Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Melanoma - drug therapy | Adult | Female | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Carcinoma, Renal Cell - drug therapy | Ovarian Neoplasms - drug therapy | Intravenous administration | Kidneys | Immune response | Disease | PD-1 protein | Tumor cells | Lung | Colorectal carcinoma | Body weight | Melanoma | Lymphocytes T | Breast cancer | Stomach cancer | Patients | Ovarian cancer | Pancreatic cancer | PD-L1 protein | Antitumor activity | Ligands | Autoimmune diseases | Gastric cancer | Clear cell-type renal cell carcinoma | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 460 - 466
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 538 - 543
Most patients with colorectal cancer die as a result of the disease spreading to other organs. However, no prevalent mutations have been associated with... 
STEM-CELLS | GENE | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | MOUSE | LEADS | RECEPTOR | MICE | GROWTH-FACTOR | TUMORIGENESIS | EXPRESSION | Intestines - drug effects | Colonic Neoplasms - genetics | Intestinal Mucosa - metabolism | Colonic Neoplasms - drug therapy | Humans | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Stem Cells - metabolism | Th1 Cells - immunology | T-Lymphocytes, Cytotoxic - drug effects | Neoplasm Metastasis - drug therapy | Neoplasm Metastasis - immunology | Colonic Neoplasms - immunology | Immunotherapy | Transforming Growth Factor beta - antagonists & inhibitors | Female | Liver Neoplasms - secondary | Disease Models, Animal | T-Lymphocytes, Cytotoxic - immunology | Transforming Growth Factor beta - immunology | Tumor Microenvironment - drug effects | Th1 Cells - drug effects | Intestines - pathology | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Drug Synergism | Tumor Microenvironment - immunology | Neoplasm Metastasis - genetics | Animals | Cell Differentiation - drug effects | Neoplasm Metastasis - pathology | Colonic Neoplasms - pathology | Alleles | Immune Evasion - drug effects | Stem Cells - drug effects | Stem Cells - pathology | Mice | Mutation | T-Lymphocytes, Cytotoxic - cytology | PD-1 protein | Liver | Colorectal carcinoma | Colorectal cancer | Stem cell transplantation | Cytotoxicity | Lymphocytes T | Metastasis | Metastases | Colon cancer | Intestine | Lymphocytes | Genetic analysis | Fibroblasts | Colon | Inhibition | Growth factors | Phenotypes | Data analysis | Liver diseases | Microsatellites | Organs | Gene expression | Patients | Signaling | Immune checkpoint | PD-L1 protein | Stem cells | Tumors | Cancer | Index Medicus
Journal Article
Journal Article